Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Thirty-four students – who are either CSL employees or the dependents of employees – received awards, including three $10,00…
On Tuesday in Marburg, Germany, CSL inaugurated its largest R&D facility under one roof – designed for collaboration and sust…
It’s almost flu season and, if you’re a twice-monthly plasma donor, CSL Plasma has your vaccination covered.
Medical research – critical in bringing new treatments to patients – gives participants control over their participation, the…
Construction began in 2020 and the 16-story building is almost complete. It’s a new anchor in the Parkville biomedical distri…
When people interact with things, like medical devices, almost anything can happen, CSL’s Monica Tavanti says. That’s why hum…
Just in time for fall, the Immune Deficiency Foundation has updated its guidance for school students.
The American Red Cross, supported by CSL Plasma, is assisting with disaster relief in the United States.
Did you know? More than 25 percent of U.S. adults have two or more health conditions.
Americas
Asia Pacific
Middle East
Europe
